HNRNPA2B1 and amyotrophic lateral sclerosis: Immediately following this report, ALS-FTD-causing mutations were identified in the LCDs of hnRNPA1 and hnRNPA2B1 that reduced the concentration necessary for this phase transition and accelerated the formation of fibrils (Kim et al. 2013).